Prof Khusru Asadullah, Professor of Dermatology, University Hospital Charite
Philippe Auby, MD is an Adult, Child and Adolescent Psychiatrist. He started his residency training in Psychiatry in 1986 and received his MD from Toulouse University of Medicine, France. In 1989 and 1990, he worked as a psychiatrist in South East Refugee Camps in Thailand. After his training in...
Dr Philippe Auby, Vice President of Global Clinical Research, Paediatric Neuro-Psychiatry, Lundbeck
Leads biomedical research in the area of inflammation and personalized medicine. Studied Medicine in Italy and trained in internal medicine and clinical immunology. Completed PhD in Immunology at the University College London (UCL), London. Completed membership of the Royal College of...
Mr Claudio Carini, Global Head Clinical Immunology and Biomarkers, Pfizer
Dr. Chelsky is the Chief Scientific Officer at Caprion Proteomics, a company using mass spectrometry to discover and validate biomarkers of disease and drug efficacy, drug mechanism of action and new targets for disease intervention. Previously he served as President of BioSignal, Inc., a...
Dr Daniel Chelsky, Chief Scientific Officer, Caprion Proteomics
Raj Chopra trained in medicine at University College London. He then completed his training in general medicine at major teaching hospitals in London, gaining a Membership of the Royal College of Physicians. He undertook a Ph.D. in cell signaling and growth receptors followed by a post doctoral...
Rajesh Chopra, Vice President of Translational Development, Celgene Corporation
Dr John Connell completed his PhD at the University of Manchester in 1996 and has over 25 years experience in Clinical Research. The majority of his research has been focused on the application of specialist scientific techniques, including healthy volunteer pharmacodynamic models, in early...
Dr John Connell, Chief Research and Development Officer, MAC Clinical Research
Ms Pia Davidsson, Associate Director, Biomarkers, Astra Zeneca
Dr Ulrik Nicolai De Lichtenberg, Senior Principle Scientist, Translational Research, LEO Pharma A/S
Ms Corina Dana Dota, Centre Director, AstraZeneca Research and Development Plc
James Dow, Director, independent consultant
Dr Gerhard Gross, Scientific Director, Johnson & Johnson
Lars Grundemar, M.D., Ph.D. is the Head of Experimental Medicine at Ferring Pharmaceuticals, Assoc. Vice President and based in Copenhagen, Denmark. He is responsible for early clinical development of compounds, mostly therapeutic peptides, but also biologics and small molecules. ...
Dr Lars Grundemar, Assoc. Vice President, Experimental Medicine and Bioanalysis, Ferring Pharmaceuticals As
Jean-Michel Guillon, Head Of Safety Pharmacology, Sanofi
Kulasiri Gunawardena, Senior Consultant, Clinical Drug Development, KG Pharma Consulting
Dr Hernandez-Fuentes studied Medicine in Universidad Complutense and then did a PhD in Immunology in Universidad de Alcalá, both in Madrid, Spain. In 1998 she moved to the UK to do a post-doc at Hammersmith Hospital, Imperial College London, working on alloimmune responses. In 2005 the research...
Dr Maria Hernandez Fuentes, Senior Lecturer in Translational Research, Kings College London
Philippe Auby, MD is an Adult, Child and Adolescent Psychiatrist. He started his residency training in Psychiatry in 1986 and received his MD from Toulouse University of Medicine, France. In 1989 and 1990, he worked as a psychiatrist in South East Refugee Camps in Thailand. After his training in...
Mr Joachim Hochel, Head of Clinical Pharmacokinetics Women's Health Specialized Therapeutics Common Mechanism Research, Bayer Healthcare Pharmaceuticals
Orest Hurko has had 15 years of biomarker and early development experience at SmithKline Beecham, GlaxoSmithKline, Wyeth, Pfizer, and at EMD Serono, after 19 years on the faculty of the Johns Hopkins University School of Medicine with a special interest in heritable disorders of the nervous...
Orest Hurko, Medical Director, Emd Serono
Dr Hazel Jones works for the CRUK Centre for Drug Development and is responsible for the ECMC Combination Alliance (Experimental Cancer Medicine Centre, http://www.ecmcnetwork.org.uk/collaborations/combinations-alliance/), which supports investigator led early phase clinical trials. The...
Hazel Jones, Head of Combination Therapies, Cancer Research U.K.
Prof Trevor Jones, Non Executive Director, SIMBEC-ORION GROUP LTD
Dr Thomas Joos, Deputy Managing Director, NMI Natural and Medical Sciences Institute at the University of Tuebingen
Dr Jens-Oliver Koopmann, , ML Consulting
I am currently Clinical Science Team Leader in Global Clinical Operations at LEO pharma where my responsibilities include building a strong alignment between Translational Research, Clinical Development and Safety and GCO in the conduct of our early portfolio. I am accountable for ensuring...
Dr Tord Labuda, Senior Principal Scientist, Clinical Science Team Leader, LEO Pharma A/S
1/2013-present Associate Director Clinical Biomarkers Biomarker Lead Oncology and Neuro VERTEX PHARMACEUTICALS (EUROPE) LTD, Abingdon, UK - Clinical biomarker lead for Vertex’s UK based research and development projects - Postulation and execution of biomarker strategies for projects in oncology...
Dr Gereon Lauer, Associate Director, Clinical Biomarkers, Vertex Pharmaceuticals Europe Ltd
Alberto Martinez has worked in Biotechs and pharma companies for over 20 years. He has a Molecular Biology and Genetic PhD, an MBA and diploma in pharmaceutical medicine. He has worked in Zeneca, Syngenta BioPharma, Aspreva Pharmaceuticals, Syntaxin and now Daiichi Sankyo in roles spanning basic...
Alberto Martinez, Director TMCP, Daiichi Sankyo
Dr Malcolm Mitchell, Senior Medical Fellow, Eli Lilly and Co
SHORT PROFILE DESCRIPTIONPhD in Immunology, MBA, former Assistant Professor (Harvard Medical School, Boston, USA).25 years of experience in the vaccine industry.Currently, Vice President Research and Pharmaceutical Development and member of the Executive Committee (Stallergenes, Paris France). ...
Mr Philippe Moingeon, Vice President of Research and Development, Stallergenes
Dr Stergios Moschos, Reader in Industrial Biotechnology, University of Westminster
Ms Devi Nair, Clinical Lead of Clinical Biochemistry and Head of Department, N.H.S. Royal Free London NHS Foundation Trust
Heiko G. Niessen, Ph.D., Principal Translational Medicine Expert for Clinical Imaging leads the Clinical Imaging Team within the Department of Translational Medicine & Clinical Pharmacology at Boehringer Ingelheim. His team develops and enables translational and clinical imaging strategies for...
Dr Heiko Niessen, Team Leader Clinical Imagining, Boehringer Ingelheim
Dr Martin O'Kane MRPharmS is Acting Head of the Clinical Trials Unit at the Medicines and Healthcare products Regulatory Agency (MHRA). He studied pharmacy at University of Aston and after completing a PhD and a post-doctorate research project at the University of Glasgow, he moved to Japan to ...
Dr Martin O’Kane, Acting Head of the Clinical Trials Unit, MHRA
Dr. Olbertz has 10 years of experience in clinical research, during which time she has taken on roles of increasing responsibility. In her current position as Senior Director of Cardiovascular Safety Services, she has played a key role in the advancement of the Celerion Cardiac Safety Service...
Dr Joy Olbertz, Senior Director, Cardiovascular Safety Services, Celerion Inc
Dr Ormarsdottir graduated with a MD from the University of Iceland. She did her training at the University hospital in Uppsala, Sweden in Internal Medicine and Gastroenterology and Hepatology, where she then held position as a consultant. She did her PhD in medicine on research related to bone...
Dr Sif Ormarsdottir, Specialist Gastroenterology and Hepatology, Chair, Hepatotoxicity Safety Knowledge Group,, AstraZeneca Ab
Marie-Laure Ozoux is leading the group of Biomarkers and Biological Analyses in Disposition, Safety and Animal Research in Sanofi, Paris. She graduated in Pharmacy (University of Paris V). She started her career at Rhone Poulenc Santé as a scientist and participated to the development of several...
Dr Marie-Laure Ozoux, Head of Biomarkers and Biological Analysis/DSAR, Sanofi
Dr. Jens Rengelshausen is a physician with board-certification in clinical pharmacology. He is holding a Senior Director position as Head of Translational Science at Grünenthal GmbH in Aachen, Germany. His current work comprises the identification and validation of biomarkers and experimental...
Dr Jens Rengelshausen, Head Translational Science, Global Early Clinical Development, Grünenthal GmbH
Dr. Rusch is an executive level business development professional and drug development scientist specializing in early clinical development services at Vince and Associates Clinical Research, providing a consultative service tailored to the needs of biotechnology and pharma clients. Dr. Rusch...
Ms Lorraine Rusch, Vice President of Business Development, Vince and Associates Clinical Research Inc
Mr Andreas Schuppert, Director, Bayer
Claudia Stark, , Bayer HealthCare
Dr Daniel Strasser, Senior Lab Head, Translational Science, Actelion
Mr Fernando Ulloa Montoya, Director, R&D Cancer Immunotherapies, GSK Vaccines
Andreas joined F. Hoffmann-La Roche after his clinical research fellowship at Leiden University as a Clinical Pharmacologist. He was responsible for clinical “Proof of Concept” studies and later became Clinical Science Leader for Cardiovascular Clinical Development.Andreas became R&D project...
Mr Andreas Wallnoefer, Global Head of Prod Development, F Hoffman La Roche Ltd
Antje Walz is Head of Quantitative Systems Pharmacology, Pharma Research and Early Development at F. Hoffmann-La Roche, Ltd. Antje received her PhD in Biology from the University of Konstanz, Germany. She has more than 10 years of experience in translational Pharmacokinetic/Pharmacodynamic...
Dr Antje Walz, Head of Quantitative Systems Pharmacology, Roche
Graeme Young, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research andDevelopment Ltd.BSc (Hons) Biochemistry from Heriot-Watt University, Edinburgh, Scotland (1982-1986)MSc Forensic Science from Strathclyde University, Glasgow, Scotland (1986-1987).Employed at GSK (or heritage companies) ...
Dr Graeme Young, Manager, Drug Metabolism and Pharmacokinetics, Glaxo Smith Kline R & D
Download Brochure
Co-located with Biomarkers World Europe:
